Wed, May 25, 2022
Tue, May 24, 2022
Mon, May 23, 2022
Sat, May 21, 2022
Fri, May 20, 2022
Thu, May 19, 2022

David Risinger Initiated (TBPH) at Buy and Held Target at $12 on, May 23rd, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-12-on-may-23rd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Risinger of SVB Leerink, Initiated "Theravance Biopharma, Inc." (TBPH) at Buy and Held Target at $12 on, May 23rd, 2022.

David has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Vikram Purohit of "Morgan Stanley" Maintained at Sell with Increased Target to $11 on, Wednesday, March 2nd, 2022
  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $12 on, Thursday, February 24th, 2022

Publication Contributing Sources